Biochemistry, Genetics and Molecular Biology
ABCG5
13%
ABCG8
12%
Absorption
10%
Acyltransferase
10%
Adenosine Triphosphate
20%
All Cause Mortality
11%
Allele
30%
Amino Acids
27%
Androgen Receptor
25%
Apolipoprotein
17%
Beta Oxidation
9%
Binding Site
9%
Blood Level
16%
Blood Pressure
49%
Body Mass
29%
C-Terminus
15%
Carcinogenesis
12%
Cell Culture
12%
Cell Membrane
19%
Chinese Hamster
9%
Cholesterol Blood Level
11%
Cholesterol Level
10%
Cholesterol Synthesis
30%
Cholesteryl Ester
14%
Cisplatin
10%
Clinical Trial
11%
Cohort Study
36%
Copurification
12%
Creatinine
9%
Cysteine
15%
Eicosanoid Receptor
83%
Endocytosis
12%
Enzyme
48%
Epidermal Growth Factor Receptor
15%
Exon
16%
Familial Hypercholesterolemia
44%
Farnesyltransferase
13%
Fatty Acid Synthesis
12%
Fibroblast
49%
Fibroblast Growth Factor 23
13%
Genetic Epidemiology
10%
Genetics
53%
Genome-Wide Association Study
10%
Glomerulus Filtration
23%
Glucocorticoid
12%
Glucose Blood Level
13%
Hepatocyte
23%
HMG-CoA
25%
Homeostasis
20%
Hypercholesterolemia
19%
Insulin Resistance
15%
Internalization
15%
Intron
10%
Iodine-125
14%
Isoform
12%
Ketogenesis
14%
Kidney Function
20%
Kinase
10%
LDL Receptor
100%
Leporidae
19%
Lipid
22%
Lipogenesis
16%
Lipoprotein
45%
Lipoprotein Blood Level
11%
Low-Density Lipoprotein
80%
Malonyl-CoA
10%
Messenger RNA
25%
Metabolic Pathway
21%
Metabolite
18%
Mouse
71%
N-Acetyltransferase
10%
N-Terminus
26%
Natriuretic Peptide
17%
Normal Human
9%
Oxidoreductase
43%
Phosphotransferase
10%
Precursor
18%
Prevalence
27%
Promoter Region
17%
Protease
12%
Receptor Gene
19%
Reductase
40%
Regulatory Element
10%
Secretion (Process)
22%
Single-Nucleotide Polymorphism
10%
Sodium-Hydrogen Antiporter
12%
SREBP Cleavage Activating Protein
13%
Sterol
75%
Sterol Regulatory Element Binding Protein 1
9%
Sterol Regulatory Element Binding Protein 1c
14%
Sterol Regulatory Element Binding Protein 2
16%
Sterol Regulatory Element-Binding Protein
59%
Surface Property
22%
Systolic Blood Pressure
16%
Transcription
28%
Transcription Factors
16%
Transgenic Mouse
16%
Triglyceride
26%
Wild Type
9%
Zebra Fish
22%
Medicine and Dentistry
Acute Kidney Injury
12%
Acute Lymphoblastic Leukemia
25%
Adenosine Triphosphate
12%
Adolescent
13%
Adverse Event
11%
Antihypertensive Agent
10%
Apoplexy
22%
Arm
15%
Atherosclerosis
8%
Atrophic Gastritis
9%
Biological Marker
23%
Biopsy
24%
Bleeding
17%
Blood Pressure
32%
Body Mass Index
18%
Brain Ischemia
31%
Cancer
11%
Carboplatin
16%
Cardiovascular Disease
35%
Cardiovascular Risk
14%
Cardiovascular System
28%
Childhood Cancer
16%
Chronic Kidney Disease
88%
Cisplatin
29%
Clinical Trial
15%
Clinician
9%
Cohort Analysis
51%
Combination Chemotherapy
10%
Cross Sectional Study
10%
Diabetes
19%
Diagnosis
17%
Disease
77%
Disease Exacerbation
12%
Drug Therapy
18%
End Stage Renal Disease
9%
Epileptic Absence
17%
Etoposide
23%
Fibroblast
9%
Fibroblast Growth Factor 23
13%
Food Allergy
11%
Gastritis
26%
Gastroesophageal Reflux
11%
Germinoma
21%
Glomerular Filtration Rate
18%
Group Trial
9%
Hazard Ratio
14%
Health Care Cost
10%
Health System
8%
Heart Failure
18%
Helicobacter Infection
24%
Helicobacter Pylori
24%
Hepatocyte
10%
Idiopathic Thrombocytopenic Purpura
34%
In Vitro
13%
Infection
33%
Intestinal Metaplasia
13%
Ischemic Heart Disease
8%
Isotopes of Calcium
9%
Kidney Function
16%
LDL Receptor
15%
Lipoprotein
11%
Low Density Lipoprotein Cholesterol
10%
Low-Density Lipoprotein
16%
Lung Cancer
19%
Malignant Neoplasm
44%
Maturity Onset Diabetes of the Young
9%
Medicine
9%
Meta-Analysis
10%
Myocardial Infarction
11%
Neonate
10%
Neoplasm
48%
Nephropathy
12%
Non Small Cell Lung Cancer
63%
Odds Ratio
21%
Oncology
45%
Overall Survival
14%
Paclitaxel
19%
Pathologist
17%
Pediatrics
18%
Phase II Trials
9%
Platelet
14%
Polyp
11%
Prevalence
42%
Pylorus
31%
Quality of Life
13%
Radiation Therapy
31%
Randomized Controlled Trial
10%
Receptor
12%
Secretion (Process)
11%
Sickle-Cell Disease
33%
Small Cell Lung Cancer
33%
Sodium Bicarbonate
13%
Sodium Ion
18%
Stomach Biopsy
9%
Stomach Cancer
19%
Stomach Mucosa
12%
Surgery
15%
Symptom
11%
Systolic Blood Pressure
15%
Urinary System
11%
Keyphrases
125I
11%
3-hydroxy-3-methylglutaryl-CoA Reductase
8%
3-hydroxy-3-methylglutaryl-coenzyme A
8%
Acute Ischemic Stroke
34%
Acute Ischemic Stroke Patients
10%
Acute Lymphoblastic Leukemia
10%
All-cause Mortality
12%
Amino Acids
10%
Androgen Receptor
13%
Androgen Resistance
16%
Atherosclerotic Cardiovascular Disease (ASCVD)
9%
Blood Pressure
20%
Body Mass Index
18%
Bogalusa Heart Study
17%
Carboplatin
17%
Carboplatin-paclitaxel
9%
Cardiovascular Disease
17%
Cardiovascular Outcomes
7%
Cardiovascular Risk
17%
Chemotherapy
28%
China
15%
Cholesterol
46%
Cholesterol Levels
10%
Cholesterol Synthesis
15%
Cholesteryl Ester
9%
Chronic Kidney Disease
48%
Chronic Renal Insufficiency Cohort
40%
Cisplatin
24%
Clinical Outcomes
14%
Combination Chemotherapy
10%
Complementary DNA (cDNA)
9%
Confidence Interval
33%
Diabetes
11%
Eastern Cooperative Oncology Group
16%
Endoplasmic Reticulum
15%
Estimated Glomerular Filtration Rate
12%
Etoposide
19%
Fibroblast Growth Factor 23 (FGF23)
12%
Fibroblasts
10%
Germ Cell Tumor
11%
Glioblastoma
8%
Group Studies
13%
Hamster
10%
Hazard Ratio
17%
Heart Failure
13%
Helicobacter Pylori (H. pylori)
16%
Helicobacter Pylori Infection
17%
Hepatocytes
8%
Heterozygote
7%
High-density Lipoprotein Cholesterol (HDL-C)
12%
Homozygous Familial Hypercholesterolemia (HoFH)
29%
Human Fibroblasts
15%
Hypertension
20%
Inflammation
10%
Insulin
16%
Ischemic Stroke
21%
Ischemic Stroke Patients
10%
Kidney
9%
Kidney Disease Progression
16%
LDL Receptor
10%
Lipids
8%
Lipoproteins
30%
Liver
34%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
21%
Low-density Lipoprotein
58%
Low-density Lipoprotein Cholesterol (LDL-C)
12%
Low-density Lipoprotein Receptor
58%
Major Disability
10%
Median Survival
8%
Monoclonal Antibody
9%
Multivariable
8%
Myocardial Infarction
11%
Na +
18%
NHE3
8%
Non-small Cell Lung Cancer (NSCLC)
37%
Obesity
9%
Odds Ratio
12%
Older Adults
10%
Paclitaxel
20%
Phase II Study
10%
Phase II Trial
20%
Plasma Membrane
7%
Proximal Convoluted Tubules
13%
Proximal Tubule
20%
Randomized Trial
8%
Rat Liver
7%
Reductase
8%
Resectable Lung Cancer
8%
Risk Factors
12%
Sickle Cell Disease
10%
Small Cell Lung Cancer
17%
SREBP Cleavage-activating Protein
8%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
45%
Sterols
28%
Systolic Blood Pressure
13%
Transgenic Mice
9%
Tumor
15%
Type 2 Diabetes Mellitus (T2DM)
8%
United States
19%
Vascular Events
8%